Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
279.31
+5.25 (1.92%)
May 2, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 8,030 employees on December 31, 2023. The number of employees decreased by 170 or -2.07% compared to the previous year.
Employees
8,030
Change (1Y)
-170
Growth (1Y)
-2.07%
Revenue / Employee
$332,660
Profits / Employee
-$79,368
Market Cap
8.01B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8,030 | -170 | -2.07% |
Dec 31, 2022 | 8,200 | 300 | 3.80% |
Dec 31, 2021 | 7,900 | -100 | -1.25% |
Dec 31, 2020 | 8,000 | -120 | -1.48% |
Dec 31, 2019 | 8,120 | -140 | -1.69% |
Dec 31, 2018 | 8,260 | 110 | 1.35% |
Dec 31, 2017 | 8,150 | -100 | -1.21% |
Dec 31, 2016 | 8,250 | 480 | 6.18% |
Dec 31, 2015 | 7,770 | 170 | 2.24% |
Dec 31, 2014 | 7,600 | -150 | -1.94% |
Dec 31, 2013 | 7,750 | 370 | 5.01% |
Dec 31, 2012 | 7,380 | 350 | 4.98% |
Dec 31, 2011 | 7,030 | 150 | 2.18% |
Dec 31, 2010 | 6,880 | 280 | 4.24% |
Dec 31, 2009 | 6,600 | 0 | - |
Dec 31, 2008 | 6,600 | 200 | 3.13% |
Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
Dec 31, 2006 | 5,400 | 200 | 3.85% |
Dec 31, 2005 | 5,200 | 0 | - |
Dec 31, 2004 | 5,200 | 400 | 8.33% |
Dec 31, 2003 | 4,800 | 200 | 4.35% |
Dec 31, 2002 | 4,600 | 300 | 6.98% |
Dec 31, 2001 | 4,300 | 500 | 13.16% |
Dec 31, 2000 | 3,800 | -300 | -7.32% |
Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
Dec 31, 1998 | 2,675 | 25 | 0.94% |
Dec 31, 1997 | 2,650 | 115 | 4.54% |
Dec 31, 1996 | 2,535 | 75 | 3.05% |
Dec 31, 1995 | 2,460 | 130 | 5.58% |
Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Bio-Rad Laboratories | 8,030 |
Penumbra | 4,200 |
Masimo | 3,800 |
Legend Biotech | 1,826 |
Exelixis | 1,310 |
Inspire Medical Systems | 1,011 |
Ascendis Pharma | 879 |
BIO News
- 1 day ago - Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference - Business Wire
- 6 days ago - Bio-Rad Announces Life Science Group Management Changes - Business Wire
- 14 days ago - Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - Business Wire
- 22 days ago - Bio-Rad's Chief Operating Officer Andrew Last to Retire - Business Wire
- 6 weeks ago - Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer - Business Wire
- 2 months ago - Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day - Business Wire
- 2 months ago - Bio Rad Labs rises after posting upbeat fourth-quarter profit - Reuters
- 2 months ago - Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results - Business Wire